A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

NCT01684345 ·Status: TERMINATED ·Phase: PHASE3

Phase 2 Study of MM-093 to Treat Patients With Uveitis

NCT00444743 ·Status: COMPLETED ·Phase: PHASE2

Minocycline for Chronic Autoimmune Uveitis

NCT05474729 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

NCT01090310 ·Status: TERMINATED ·Phase: PHASE3

A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis

NCT00404885 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

NCT02258867 ·Status: TERMINATED ·Phase: PHASE3

A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis

NCT05523765 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis

NCT04798755 ·Status: UNKNOWN ·Phase: PHASE3

Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy

NCT06821971 ·Status: ACTIVE_NOT_RECRUITING

Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis

NCT05105347 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study

NCT01261169 ·Status: UNKNOWN

Observation on the Treg in the Uveitis Patients

NCT01306474 ·Status: COMPLETED

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

NCT00404612 ·Status: COMPLETED ·Phase: PHASE3

Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

NCT01900431 ·Status: COMPLETED ·Phase: PHASE2

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

NCT01103024 ·Status: WITHDRAWN ·Phase: PHASE3

Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)

NCT01965145 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis

NCT01327664 ·Status: WITHDRAWN ·Phase: PHASE3

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT03834753 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Patients With Active Uveitis

NCT01138657 ·Status: COMPLETED ·Phase: PHASE3

Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis Patients

NCT05155592 ·Status: UNKNOWN ·Phase: PHASE2

Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation

NCT00415506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD

NCT00469352 ·Status: COMPLETED ·Phase: PHASE3

Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis

NCT02706704 ·Status: RECRUITING ·Phase: PHASE2

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

NCT05576792 ·Status: COMPLETED

Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis

NCT00070759 ·Status: COMPLETED ·Phase: PHASE2